Abstract
As part of the 2018 Immunotherapy Bridge congress (November 28-29, Naples, Italy), the Great Debate session featured counterpoint views from leading experts on four topical clinical issues in immunotherapy today. These were: the relative importance of adaptive versus innate immunity in the anti-cancer immune response; the merits of combination versus sequential immunotherapy regimens in the treatment of cancer; the advantages and disadvantages of murine models of cancer versus humans in order to evaluate immunotherapy; and whether or not mechanisms of resistance to immunotherapy differ between different cancers. Discussion of these important topics are summarised in this report.
Original language | English |
---|---|
Article number | 221 |
Journal | Journal for ImmunoTherapy of Cancer |
Volume | 7 |
Issue number | 1 |
DOIs | |
Publication status | Published - Aug 15 2019 |
Keywords
- Anti-CTLA-4
- Anti-PD-1
- Cancer
- Combination therapy
- Immunity
- Immunotherapy
- Treatment resistance
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Molecular Medicine
- Oncology
- Pharmacology
- Cancer Research